Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMLA vs Lidocaine for Vulvar Biopsy
NCT03654417Phase 4Terminated
- Sponsor
- Duke University
- Start
- Sep 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lidocaine + prilocaine in pain (2 arms), sponsored by Duke University. Primary endpoint: Highest Pain at 5 months. Started Sep 2018; status: terminated.
02
Drugs
lidocaine + prilocaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03654417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03654417.